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Abstract 
Objective: Angiosarcoma is a rare neoplasm 
typically presenting in the skin and superficial 
soft tissues, with an equal female-to-male ratio. 
We present a woman with recurrent vulvar 
lesions and a history of melanoma found to have 
angiosarcoma. 
Case: A 67-year-old woman presented with a 
seven month history of recurrent vulvar lesions 
with symptoms of discomfort and bleeding.  The 
histopathological diagnosis revealed high-grade 
angiosarcoma. Computed tomographic imaging 
with contrast and positron emission tomography 
revealed disseminated disease. She underwent 
chemotherapy and radiation but died within one 
year of diagnosis.  
Conclusions: The prognosis for patients with 
angiosarcoma is generally poor, especially with 
disseminated disease. Early detection remains 
the key element in maximizing patient outcomes.   
1University of Iowa Hospitals and Clinics, 
Department of Obstetrics and Gynecology, Iowa 
City, Iowa 
Introduction 
Angiosarcomas comprise less than 2% 
of all sarcomas, are commonly 
aggressive, and disseminate widely.1-3 
They often present with a bruise-like 
appearance which can progress to 
nodular and ulcerated lesions. While 
angiosarcomas can arise anywhere in 
the body, they rarely occur in the female 
genital tract.4  The lung and liver are the 
most common sites of metastases.1 
Primary angiosarcomas arise without  
recognized associated risk factors.2 
Certain familial syndromes such as Li 
Fraumeni and neurofibromatosis, as 
well as environmental factors such as 
radiation exposure, chronic 
inflammation, and foreign body material 
are associated with development of 
secondary angiosarcomas.1,2,4,5 We 
present a case of angiosarcoma 
occurring in a woman with a history of 
melanoma. 
Case Report 
A 67-year-old gravida 5 para 4 woman 
presented to our tertiary referral center 
with a seven month history of recurrent 
vulvar lesions. She reported onset and 
recurrence of a single vulvar lesion 
following incision and drainage on two 
occasions; once by her dermatologist 
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and once by her gynecologist. 
Subsequently, she noted the presence 
of additional similar lesions which 
prompted referral for further evaluation 
given a history of melanoma excised 
from her back four years previously.  
At her initial office visit with our clinic, 
the patient reported intermittent, mild to 
moderate vulvar discomfort as well as 
bleeding from the lesions. Her history 
was notable for: total abdominal 
hysterectomy and bilateral salpingo-
oophorectomy for symptomatic fibroid 
uterus in 2010, normal Pap smear three 
years prior with no history of abnormal 
pap smears, and melanoma treated with 
excisional biopsy four years prior.  Her 
general physical examination was 
remarkable only for multiple black, 
protuberant vulvar lesions, concerning 
for melanoma. A lesion on the right 
mons was approximately 1.8 cm in 
diameter (Figure 1).  
 
Figure 1. Right mons lesion 
A second lesion on the left inferior 
lateral labia majora was approximately 
2.5 cm in diameter. A 0.5 cm diameter 
nodular lesion of the right inferior labia 
majora was also present (Figure 2). The 
mons also had a hyperpigmented 
erythematous and brown patch. 
Speculum exam revealed normal 
vaginal mucosa with no lesions or 
excoriations identified. There was no 
inguinal lymph node adenopathy 
palpable. 
 
Figure 2. Right labia majora lesion 
Due to the number of lesions present, 
excisional biopsy was limited to the two 
largest lesions. Microscopic evaluation 
showed large, hyperchromatic, 
pleomorphic tumor cells. 
Immunohistochemistry showed the 
tumor cells were positive for CD34 and 
CD31. Immunohistochemical analysis of 
the lesions showed scattered dermal 
staining for IgG and IgM. C3 and 
fibrinogen were identified in the walls of 
superficial vessels. The final 
histopathological diagnosis was high-
grade angiosarcoma.  
Patient was referred to gynecology-
oncology and hematology-oncology.  
Concurrent evaluation locally for 
abdominal pain and by the referral 
services following histopathological 
diagnosis confirmed disseminated 
angiosarcoma with hepatic, pancreatic, 
and renal involvement on computed 
tomographic imaging with contrast and 
positron emission tomography. Given 
the disseminated disease and poor 
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response to treatment, she underwent 
several interventions including 
chemotherapy with paclitaxel; a trial 
study using paclitaxel, valproic acid, and 
bevacizumab; adrimycin; and radiation. 
Significant disease course complications 
included pathologic left hip fracture and 
aortic stenting for metastatic lesion 
involving the descending thoracic aorta, 
in addition to multiple admissions for 
fever and infections. Within one year of 
diagnosis, she died of complications 
from her metastatic disease. 
Discussion 
A recent case study and review of the 
literature identified 51 patients with 
primary angiosarcoma of the female 
genital tract.6 Two of the 51 cases 
presented with vulvar lesions; both had 
localized disease unlike our case in 
which disseminated disease was 
present at the time of diagnosis. 
While a broad differential may be 
formulated for vulvar lesions, multiple 
findings should increase the suspicion of 
malignancy as in this case presentation. 
These include: asymmetry, border 
irregularity, color variation, rapid 
change, lack of healing, and bleeding. 
Biopsy is necessary to differentiate 
between benign and malignant lesions. 
Although melanoma has not been 
identified as a specific risk factor, a 
recent analysis from the Surveillance, 
Epidemiology, and End Results (SEER) 
program identified 26% (of 434 patients 
with angiosarcoma) had a prior primary 
cancer.3 An increased index of suspicion 
for malignancy may have prompted 
early biopsy diagnosis and improved 
outcome. 
In addition to surgery to obtain negative 
margins, treatment may include 
radiation and/or chemotherapy. 
Extensive local or radical excision is the 
preferred treatment for angiosarcoma 
when localized.7 Chemotherapy utilizing 
adrimycin plus ifosfamide has been the 
initial treatment for soft tissue sarcoma.8 
Recently, multiple different 
chemotherapy combinations have been 
tested for the treatment of 
angiosarcoma.4,8,9 
The prognosis for patients with vulvar 
sarcomas has been generally poor due 
to lack of clinical experience, the 
aggressive nature of the disease, and 
the poor response to chemotherapy and 
radiotherapy employed. The overall 
course appears to be greatly influenced 
by the size and extent of infiltration of 
the tumor. Most cases have an 
aggressive behavior with a median 
survival of seven months, and 5 year 
survival of about 35%.5 Palliative 
chemotherapy for disseminated disease 
is hampered by toxicities and poor 
response rates.  
Conclusion 
Given the overall poor prognosis of 
angiosarcoma, early detection remains 
the key element in maximizing patient 
outcome. 
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